A recent encounter during a free screening on our Destination: Healthy Skin RV showed, once again, how imperative it is to check in with your skin regularly. It could very well save you time and money in the future, and may even save your life.
Growing up in the 1960s and 1970s, we had a different relationship with the sun. We didn’t think we looked good or “healthy” unless we had a tan. Ironic, isn’t it? I spent many hours in my teens and 20s laying out in the sun – burn, peel, repeat…until the tan took hold.
I recently had a skin cancer removed, and I’m worried about recurrence. I know I’m now at higher risk for more skin cancers, but can that same cancer come back even after it’s been treated?
Each year, we award several grants to dermatology residents, fellows and young faculty to fund research and clinical studies related to skin cancer. This year, the Todd Nagel Memorial Award was given to Dr. William Damsky, researcher at Yale University, for his study “Elucidating and Overcoming Mechanisms of Immunotherapy Resistance in Melanoma.”
With the recent FDA approval of the drug nivolumab (Opdivo®, previously approved for stage IV melanoma) as a treatment for stage III melanoma, we have reached the next important phase in the immunotherapy revolution. It is a revolution that most of the world’s top experts believe will one day, very possibly within a decade, turn advanced (stages III and IV) melanoma into a chronic, or even curable, disease rather than a deadly one.
In the summer of 2006, Kevin noticed a mole on his shoulder that seemed to have changed colors, so he went to see a dermatologist. A biopsy determined that the mole was a malignant melanoma.
When Nicole Kinnunen started dating her husband-to-be, she spotted a large, strange-looking mole on his leg. He told her it was nothing. Eleven years after they married, that melanoma left their family without a husband and father.